Login

Forgot password?
Sign up today and your first download is free.
REGISTER

Opioids

March 02, 2018 | Daily News

Congress’ Medicaid advisory commission is calling on HHS to clarify what the commission described as widespread confusion among providers and patients over a 46-year-old privacy law intended to protect the privacy of people treated for drug addiction.

March 01, 2018 | Daily News

The House Energy & Commerce health subcommittee will focus its next two legislative hearings on opioid bills aimed at enhancing addiction treatment and recovery, as well as legislation dealing with insurance coverage, E&C Committee Chair Greg Walden (R-OR) said during a keynote speech at the Chamber of Commerce’s Combating the Opioid Crisis forum Thursday (March 1).

March 01, 2018 | Daily News

A panel of industry stakeholders and addiction and medicine specialists raised concerns at a House hearing Wednesday (Feb. 28) that research could be stifled and opioid promotion increased under a bill that would amend the Controlled Substances Act to add a sixth scheduling category and another that would mandate 12 hours of opioid prescriber education.

February 28, 2018 | Daily News

Opioid-related hospitalizations increased between 2013 and 2015 as some states instituted Medicaid expansion, but the percentage of those where the patient was uninsured fell more sharply in expansion states, according to a report released Wednesday (Feb. 28) by the Center on Budget and Policy Priorities.

February 28, 2018 | Daily News

A bipartisan group of senators on Tuesday (Feb. 27) introduced updated opioid legislation that builds on the Comprehensive Addiction and Recovery Act signed into law in 2016.

February 27, 2018 | Daily News

The Department of Justice has launched a task force aimed at holding opioid manufacturers accountable for unlawful marketing practices and ensuring distributors, including pharmacies and physicians, obey Drug Enforcement Administration rules designed to prevent diversion and improper prescribing, DOJ announced Tuesday (Feb. 27).

February 27, 2018 | Daily News

The Pew Charitable Trusts says ensuring Medicare and Medicaid programs cover all approved medication-assisted treatment (MAT) and levels of care as laid out by the American Society for Addiction Medicine (ASAM) is one way Congress could help improve access to opioid use disorder treatment.

February 26, 2018 | Daily News

HHS Secretary Alex Azar on Saturday (Feb. 24) pledged to expand the use of medication-assisted treatments (MAT) to treat opioid addiction, telling the National Governor's Association that FDA will soon release two pieces of draft guidance aimed at boosting development of new therapies.

February 26, 2018 | Daily News

FDA's Office of Prescription Drug Promotion issued a warning to the maker of an abuse-deterrent opioid for allegedly understating the risks of the product, which included printing the limitations of abuse-deterrent technology below the benefits.

February 20, 2018 | Daily News

The Biotechnology Innovation Organization (BIO) in a newly released report found that development of and investment in novel pain medicines has been sorely lacking over the past decade, with only two novel chemical entities -- those with no prior approval history -- entering the market since 2007.

February 15, 2018 | Daily News

The future of a number of pain patient advocacy organizations and professional societies may be on shaky ground following the Tuesday (Feb. 13) release of a damning report that revealed 13 of these groups -- along with a non-patient-focused organization, the Washington Legal Foundation -- received nearly $9 million in funding over a five-year period from major opioid manufacturers.

February 15, 2018 | Daily News

The future of a number of pain patient advocacy organizations and professional societies may be on shaky ground following the Tuesday (Feb. 13) release of a damning report that revealed 13 of these groups -- along with a non-patient-focused organization, the Washington Legal Foundation -- received nearly $9 million in funding over a five-year period from major opioid manufacturers.

February 15, 2018 | Daily News

A number of pain management-focused patient advocacy groups and professional societies are on the defense after the release of a report showing that about 14 groups received nearly $9 million in funding from opioid manufacturers over a five-year period.

February 12, 2018 | Daily News

The Trump administration's newly released fiscal 2019 budget allocates $10 billion across HHS to address the opioid epidemic, $10 million of which would be dedicated to FDA investment in regulatory science and tools for stemming opioid abuse and misuse.

February 07, 2018 | Daily News

The draft budget deal announced by Senate leaders Wednesday (Feb. 7) includes a provision that would for the first time allow hospitals and doctors' offices to share Medicare claims data with standalone Part D prescription drug plans.

February 07, 2018 | Daily News

Senate Majority Leader Mitch McConnell (R-KY) announced a budget deal with Senate Democrats on Wednesday (Feb. 7) that includes $6 billion to fight the opioid and mental health crises, and raises non-defense discretionary spending.

February 07, 2018 | Daily News

FDA is in talks with Congress -- and has had internal agency discussions -- to assess the agency’s authority to require all immediate-release (IR) formulations of opioids be packaged in three-, seven- or 14-day blister packs, FDA Commissioner Scott Gottlieb told stakeholders during a Tuesday (Feb. 6) event held by the Alliance for a Stronger FDA.

February 07, 2018 | Daily News

FDA Commissioner Scott Gottlieb touted the potential for FDA to use its Sentinel System to study the long-term effects and prescribing of opioids and how long-term use can lead to addiction.

February 07, 2018 | Daily News

A coalition of health care stakeholders representing distributors, caregivers, mental health advocates, pharmacists, patient education advocates and physician assistants have formed Allied Against Opioid Abuse (AAOA), a coalition aimed at educating health care providers, pharmacists and the public about responsible prescription opioid prescribing and use.

February 06, 2018 | Daily News

FDA officials met Tuesday (Feb. 6) with House Energy & Commerce Committee members, including Rep. David McKinley (R-WV), to discuss policies to strengthen FDA’s power to curb opioid abuse, including enshrining in law FDA’s ability to consider drug-abuse risk in product reviews.

Pages